India markets open in 2 hours 4 minutes
  • BSE SENSEX

    48,803.68
    +259.62 (+0.53%)
     
  • Nifty 50

    14,581.45
    +76.65 (+0.53%)
     
  • Dow

    34,035.99
    +305.10 (+0.90%)
     
  • Nasdaq

    14,038.76
    +180.92 (+1.31%)
     
  • BTC-INR

    4,706,739.00
    -10,574.00 (-0.22%)
     
  • CMC Crypto 200

    1,389.80
    +8.85 (+0.64%)
     
  • Hang Seng

    28,827.17
    +34.03 (+0.12%)
     
  • Nikkei

    29,673.60
    +30.91 (+0.10%)
     
  • EUR/INR

    89.3621
    -0.2216 (-0.25%)
     
  • GBP/INR

    102.7761
    -0.3601 (-0.35%)
     
  • AED/INR

    20.3230
    0.0000 (0.00%)
     
  • INR/JPY

    1.4540
    +0.0033 (+0.23%)
     
  • SGD/INR

    55.9460
    -0.1150 (-0.21%)
     

AM Best Assigns Issue Credit Ratings to Cigna Corporation’s New Senior Unsecured Notes

·3-min read

AM Best has assigned Long-Term Issue Credit Ratings of "bbb" to the $500 million .613% senior unsecured notes due 2024, $800 million 1.25% senior unsecured notes due 2026, $1.5 billion 2.375% senior unsecured notes due 2031 and $1.5 billion 3.4% senior unsecured notes due 2051 recently issued by Cigna Corporation (Cigna) (headquartered in Bloomfield, CT) [NYSE:CI]. The outlook assigned to these Credit Ratings (ratings) is stable. The existing ratings of Cigna and its subsidiaries are unchanged. The proceeds of the recent $4.3 billion of aggregate debt, issued on March 1, 2021, will be used to redeem upcoming 2021, 2022 and 2023 issues held at various entities, as well as for general corporate purposes.

AM Best notes that Cigna has maintained relatively high financial leverage, which had come down to just over 39% at year-end 2020 and coverage improving noticeably given strong earnings reported for the year. While the March 2021 debt issues will be used to redeem upcoming 2021, 2022 and 2023 maturities, with additional legacy Cigna Holding Company debt also maturing this month, this debt issue will cause a temporary increase in financial leverage in the interim. However, Cigna has moderated its leverage post transaction, which was over 50% at the time of the close of the Express Scripts, Inc. acquisition. Cigna remains committed to deleveraging, and management has indicated it expects the company’s financial leverage to return to its targeted range of below 40% by year-end 2021.

AM Best expects Cigna’s financial deleveraging to be driven by the stronger earnings reported in 2020 and related dividends from Cigna’s insurance entities, solid nonregulated earnings from its Evernorth health services segment and additional one-time capital sources, such as a portion of the proceeds from the sale of its group employee benefits business - which closed at year-end 2020 - to help reduce outstanding debt.

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best’s Credit Ratings. For information on the proper media use of Best’s Credit Ratings and AM Best press releases, please view Guide for Media - Proper Use of Best’s Credit Ratings and AM Best Rating Action Press Releases.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2021 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210304006006/en/

Contacts

Joseph Zazzera, MBA
Director
+1 908 439 2200, ext. 5797
joseph.zazzera@ambest.com

Sally Rosen
Senior Director
+1 908 439 2200, ext. 5280
sally.rosen@ambest.com

Christopher Sharkey
Manager, Public Relations
+1 908 439 2200, ext. 5159
christopher.sharkey@ambest.com

Jim Peavy
Director, Communications
+1 908 439 2200, ext. 5644
james.peavy@ambest.com